How to Control Impurities during API drug manufacturing
Posted: February 19, 2018
Dr. Rajesh Shukla, Vice President Research and Development at PCI Synthesis Talks about Controlling Impurities during API drug manufacturing.
Related posts:
Coming Clean on Cleanroom Operations in GMP Manufacturing
10 Steps to Control or Eliminate Genotoxic Impurities in API Manufacturing
The Most Important API Scale-Up Lessons Learned
How to Handle Pesky Surprises in API Manufacturing
Generic Drug Makers Continue to Face Hurdles in Race to Make Drugs More Affordable